Status:
UNKNOWN
Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Cutaneous Leishmaniasis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The aim of the project is to determine whether daylight activated photodynamic therapy is effective in treating cutaneous leishmaniasis caused by L. major and L. tropical. PDT is classically performe...
Eligibility Criteria
Inclusion
- At least 2 skin lesions with leishmania caused by L. major or L. tropica
Exclusion
- Pregnant or lactating women
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00840359
Start Date
September 1 2009
End Date
December 1 2012
Last Update
August 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, IL-91010